Calendar Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Market Closed - Nyse 04:00:01 2024-04-24 pm EDT 5-day change 1st Jan Change
278.2 USD -2.48% Intraday chart for Bio-Rad Laboratories, Inc. -4.35% -13.84%

Chart calendar Bio-Rad Laboratories, Inc.

be64d.BAoz2HanG3BG-ekXFMo1WsFS8GUg1k-J-j_WoGly_20.XWtHoC_ALkIXvpFgfrp3NY9_mS90iQnjq3mmlzk7lSd1RXWbM85tJByvoA~67888a3e8997864e237fe70cfa5d59b4

Upcoming events on Bio-Rad Laboratories, Inc.

2024-05-07 04:15 pm Q1 2024 Earnings Release
2024-05-07 05:00 pm Q1 2024 Earnings Call
2024-05-13 RBC Capital Markets Global Healthcare Conference
2024-07-24 Q2 2024 Earnings Release (Projected)
2024-10-23 Q3 2024 Earnings Release (Projected)
2025-02-12 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)

Past events on Bio-Rad Laboratories, Inc.

2024-02-29 02:30 pm Citi Unplugged Medtech and Life Sciences Access Day
2024-02-15 05:00 pm Q4 2023 Earnings Call
2024-02-15 04:15 pm Q4 2023 Earnings Release
2024-01-07 JPMorgan Healthcare Conference
2023-10-26 05:00 pm Q3 2023 Earnings Call
2023-10-26 04:15 pm Q3 2023 Earnings Release
2023-09-07 11:00 am Wells Fargo Healthcare Conference
2023-08-03 05:00 pm Q2 2023 Earnings Call
2023-08-03 04:15 pm Q2 2023 Earnings Release
2023-06-08 03:00 pm Jefferies Global Healthcare Conference
2023-05-17 03:35 pm RBC Global Healthcare Conference
2023-05-04 05:00 pm Q1 2023 Earnings Call
2023-05-04 04:15 pm Q1 2023 Earnings Release
2023-04-25 07:00 pm Annual General Meeting
2023-03-02 11:45 am Citi Healthcare Services Medtech Tools & HCIT Conference
2023-02-16 05:00 pm FY 2022 Earnings Call
2023-02-16 04:05 pm FY 2022 Earnings Release
2023-01-10 07:30 pm JP Morgan Healthcare Conference
2022-11-08 02:00 pm Credit Suisse Healthcare Conference
2022-10-27 05:00 pm Q3 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
2 312
2 329
-0.73%
2 546
2 430
4.76%
2 923
2 893
1.04%
2 802
2 816
-0.49%
2 671
2 676
-0.18%

2 713

EBITDA
Million USD
Released
Forecast
Spread
390
406
-4.12%
537
522
2.96%
677
678
-0.04%
668
635
5.14%
536
521
2.92%

490

EBIT
Million USD
Released
Forecast
Spread
279
294
-5.39%
427
403
5.8%
571
598
-4.49%
524
530
-1.09%
379
383
-1.13%

361

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
4 908
3 985
23.15%
5 438
694
683.59%
0,00
0,00
-
-850
503
-269.07%

570

Net income
Million USD
Released
Forecast
Spread
0,00
0,00
-
3 806
3 087
23.3%
4 246
541
684.82%
-3 628
-3 508
-3.42%
-637
392
-262.67%

444

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
126
102
23.37%
141
17,9
683.94%
0,00
0,00
-
-21,8
13,5
-262.11%

15,3

Announcement Date13/02/2011/02/2110/02/2216/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
733
732
0.11%
700
677
3.48%
691
674
2.6%
681
683
-0.28%
730
741
-1.45%
677
689
-1.8%
681
696
-2.12%
632
692
-8.61%
681
687
-0.79%

626


660


670


737


651

EBITDA
Million USD
Released
Forecast
Spread
140
140
0.06%
179
138
30.25%
156
135
16.12%
132
140
-5.26%
156
167
-6.51%
149
151
-1.79%
138
134
2.51%
113
143
-21.03%
137
136
0.61%

91,3


111


127


159


116

EBIT
Million USD
Released
Forecast
Spread
113
108
4.14%
154
109
41.6%
130
106
23.09%
106
111
-4.46%
127
140
-9.16%
84,2
122
-31.13%
108
106
2.07%
81,6
112
-27.14%
105
107
-1.39%

61,8


81,4


92,6


124


83,5

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread


















-1 500
108
-1491.07%





















Net income
Million USD
Released
Forecast
Spread












828
953
-13.17%



-1 162
83,6
-1490.39%



350

















EPS
USD
Released
Forecast
Spread









-5,52
2,63
-309.89%






-39,6
2,81
-1508.9%





















Announcement Date10/02/2228/04/2228/07/2227/10/2216/02/2304/05/2303/08/2326/10/2315/02/24-----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIO Stock
  4. Calendar Bio-Rad Laboratories, Inc.